Throne Biotechnologies (Throne) has been awarded as one of top three biotech companies in the Reuters' Global Health Initiative, which distributes the Throne’s documentary film on Reuters.com.
Dr. Yong Zhao, founder and CEO at Throne, developed a unique Stem Cell Educator therapy 20 years ago, and achieved the FDA-approved Regenerative Medicine Advanced Therapy (RMA) designation for the treatment of type 1 diabetes. Recently, multicenter clinical trials have demonstrated the clinical safety and efficacy in the United States, China and Spain. The clinical outcomes are encouraging for the patients suffering from multiple inflammatory and autoimmune diseases.